Skip to content

What Is The Most Important New Drug OF 2012 ?: Forbes Perspective

December 28, 2012

According to a December 27, 2012 Forbes article titled, “The Most Important New Drug Of 2012”, Vertex Pharmaceuticals’ orphan drug Kalydeco (Ivacaftor) for Cystic Fibrosis, “stands out for its scientific and medical importance … is a triumph of genetics and drug development, the first medicine to directly affect the genetic defect that causes the disease …”.

According to the article, Kalydeco makes medical history for 3 reasons :

1) Triumph of Personalized Medicine

2) Power of a patient advocacy organization, the Cystic Fibrosis Foundation, for helping in the development of the drug

3) Price : $294,000/year/patient.

The article identifies other important drugs for 2012.

Copyright © 2012-2013, Orphan Druganaut Blog. All rights reserved.

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: